Similarly, an earlier study from Kong et al. indicates that vtRNA2-1-5p has oncogenic activity linked to cervical cancer progression and the vtRNA2-1-5p also directly targets p53 expression.150. This evidence concerns the gene TP53 and cervical carcinoma.